NO178892C - Antibiotikum betegnet kedarcidinkromofor og fremgangsmåte til fremstilling og anvendelse derav, samt et farmasöytisk preparat omfattende kedarcidinkromofor - Google Patents

Antibiotikum betegnet kedarcidinkromofor og fremgangsmåte til fremstilling og anvendelse derav, samt et farmasöytisk preparat omfattende kedarcidinkromofor

Info

Publication number
NO178892C
NO178892C NO923260A NO923260A NO178892C NO 178892 C NO178892 C NO 178892C NO 923260 A NO923260 A NO 923260A NO 923260 A NO923260 A NO 923260A NO 178892 C NO178892 C NO 178892C
Authority
NO
Norway
Prior art keywords
kedarcidine
chromophore
preparation
well
pharmaceutical composition
Prior art date
Application number
NO923260A
Other languages
English (en)
Norwegian (no)
Other versions
NO178892B (no
NO923260L (no
NO923260D0 (no
Inventor
John E Leet
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO923260D0 publication Critical patent/NO923260D0/no
Publication of NO923260L publication Critical patent/NO923260L/no
Publication of NO178892B publication Critical patent/NO178892B/no
Publication of NO178892C publication Critical patent/NO178892C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO923260A 1991-09-26 1992-08-20 Antibiotikum betegnet kedarcidinkromofor og fremgangsmåte til fremstilling og anvendelse derav, samt et farmasöytisk preparat omfattende kedarcidinkromofor NO178892C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/763,465 US5143906A (en) 1991-09-26 1991-09-26 Kedarcidin antitumor chromophore and pharmaceutical composition containing same

Publications (4)

Publication Number Publication Date
NO923260D0 NO923260D0 (no) 1992-08-20
NO923260L NO923260L (no) 1993-03-29
NO178892B NO178892B (no) 1996-03-18
NO178892C true NO178892C (no) 1996-06-26

Family

ID=25067899

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923260A NO178892C (no) 1991-09-26 1992-08-20 Antibiotikum betegnet kedarcidinkromofor og fremgangsmåte til fremstilling og anvendelse derav, samt et farmasöytisk preparat omfattende kedarcidinkromofor

Country Status (17)

Country Link
US (1) US5143906A (fr)
EP (1) EP0534137A3 (fr)
JP (1) JPH06179623A (fr)
KR (1) KR930005632A (fr)
CN (1) CN1032235C (fr)
AU (1) AU647300B2 (fr)
CA (1) CA2075453A1 (fr)
FI (1) FI923827A (fr)
HU (1) HU211108B (fr)
IL (1) IL102942A0 (fr)
MX (1) MX9204765A (fr)
NO (1) NO178892C (fr)
NZ (1) NZ244149A (fr)
PL (1) PL168918B1 (fr)
RU (1) RU2067117C1 (fr)
TW (1) TW215900B (fr)
ZA (1) ZA926421B (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3706729A (en) * 1963-11-21 1972-12-19 Andrew David Batcho Antibiotics and processes for their preparation
US5001112A (en) * 1988-04-12 1991-03-19 Bristol-Myers Company Antitumor antibiotic kedarcidin

Also Published As

Publication number Publication date
NO178892B (no) 1996-03-18
CA2075453A1 (fr) 1993-03-27
MX9204765A (es) 1993-03-01
TW215900B (fr) 1993-11-11
PL168918B1 (pl) 1996-05-31
HU211108B (en) 1995-10-30
NO923260L (no) 1993-03-29
KR930005632A (ko) 1993-04-20
FI923827A (fi) 1993-03-27
CN1073447A (zh) 1993-06-23
JPH06179623A (ja) 1994-06-28
RU2067117C1 (ru) 1996-09-27
US5143906A (en) 1992-09-01
EP0534137A3 (en) 1994-07-06
PL295725A1 (en) 1993-04-05
IL102942A0 (en) 1993-01-31
EP0534137A2 (fr) 1993-03-31
AU647300B2 (en) 1994-03-17
FI923827A0 (fi) 1992-08-26
ZA926421B (en) 1993-03-01
NO923260D0 (no) 1992-08-20
NZ244149A (en) 1994-01-26
HUT62908A (en) 1993-06-28
AU2080092A (en) 1993-04-01
CN1032235C (zh) 1996-07-10

Similar Documents

Publication Publication Date Title
DK42093D0 (da) Administrationsmetode
FI941137A (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
KR900700485A (ko) 티에노피리딘, 제조방법, 중간체 및 약제학적 조성물
IS3720A7 (is) Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
NO924768L (no) Farmasoeytisk preparat og fremgangsmaate for dets fremstilling
NO308533B1 (no) Heteroarylaminer, anvendelse derav og farmasøytisk preparat
DK1023900T3 (da) Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf
NO943888D0 (no) Farmasöytisk preparat
NO306401B1 (no) Oksazolidindionderivater, farmasöytisk preparat inneholdende slike derivater, og deres anvendelse
FI962445A0 (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
NO962694D0 (no) Percutant farmasöytisk preparat
NO950022L (no) Smaksfremmende preparat inneholdende kollidalt silika, samt fremgangsmåte til fremstilling og anvendelse derav
NO307092B1 (no) Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding
BR9200323A (pt) Formulacao de tiol-eno curavel,e sua composicao
DK0562583T3 (da) Hidtil ukendte alkylendiammoniumdiclavulanatderivater, fremgangsmåde til fremstilling deraf samt anvendelse deraf
NO942303D0 (no) Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
FI952324A0 (fi) Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet
DK132790A (da) Antiinflammatoriske og analgetiske forbindelser, praeparater deraf og metoder til fremstilling og anvendelse deraf
NO953673L (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
KR900701751A (ko) 치환 알릴아민 유도체, 그의 제조방법 및 그의 용도
FI941914A (fi) 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö
NO303637B1 (no) 7-disubstituert-metyl-4-okso-3H,5H-pyrrolo-£3,2-d|pyrimidin, farmas°ytisk preparat, og anvendelse derav
FI955679A0 (fi) Piperidiinijohdannaisia, niiden valmistus ja käyttö